Let Us Assess Your Digital Footprint
Driving Brand Opportunity Through Social Media Advocacy
With social networks playing an increasingly important role in the healthcare decision-making process, pharmaceutical companies are starting to join the conversation. So how can pharmaceutical marketers assess the impact of their social media activities? The answer lies in a new metric—social media advocacy.
True brand opportunity lies in building advocacy. And advocacy goes beyond traditional measures of “Likes” and “Followers” to evaluate impact. Strong advocacy strategies identify the best social experiences for engaging target audiences and motivating them to take action. To create the most productive digital strategies, companies should perform a full diagnostic assessment of all their digital channels.
Learn how in ghg’s article on social media advocacy.
Key Provisions of the ACA Go Into Effect Next Year. What Are You Doing to Prepare?
When the Supreme Court upheld the Affordable Care Act (ACA), the pharmaceutical landscape changed forever. As several key provisions take effect in the coming months, how can pharmaceutical manufacturers thrive in a radically different environment?
WG Consulting, a ghg company, provides insights with its webinar in Building Winning Strategies in an ACA World. Download the webinar presentation to learn:
- What research reveals about how doctors, payers, patients and pharma are reacting to the ACA—and how that compares to consumer responses
- What the US can learn from Europe
- How you need to re-define value messaging
Click here to see the webinar presentation and learn how to map out an ACA success strategy.